Chemoinformaics analysis of ISOMASTICADIENONALIC ACID
| Molecular Weight | 468.678 | nRot | 6 |
| Heavy Atom Molecular Weight | 424.326 | nRig | 24 |
| Exact Molecular Weight | 468.324 | nRing | 4 |
| Solubility: LogS | -4.518 | nHRing | 0 |
| Solubility: LogP | 4.564 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 82.6469 |
| nHD | 1 | BPOL | 46.7451 |
| QED | 0.261 |
| Synth | 4.845 |
| Natural Product Likeliness | 3.436 |
| NR-PPAR-gamma | 0.971 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.441 |
| Pgp-sub | 0 |
| HIA | 0.013 |
| CACO-2 | -5.233 |
| MDCK | 0.0000141 |
| BBB | 0.655 |
| PPB | 0.820426 |
| VDSS | 0.924 |
| FU | 0.0364238 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.847 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.907 |
| CYP2c9-inh | 0.173 |
| CYP2c9-sub | 0.874 |
| CYP2d6-inh | 0.105 |
| CYP2d6-sub | 0.405 |
| CYP3a4-inh | 0.286 |
| CYP3a4-sub | 0.241 |
| CL | 5.748 |
| T12 | 0.167 |
| hERG | 0.011 |
| Ames | 0.014 |
| ROA | 0.017 |
| SkinSen | 0.204 |
| Carcinogencity | 0.104 |
| EI | 0.196 |
| Respiratory | 0.887 |
| NR-Aromatase | 0.626 |
| Antiviral | Yes |
| Prediction | 0.629571 |